Comparison of the glycemic effects of rosiglitazone and pioglitazone in triple oral therapy in type 2 diabetes

被引：25
|
作者：
Tran, Michael T. [1 ]
Navar, Maria D. [1 ]
Davidson, Mayer B. [1 ]
机构：
[1] Charles R Drew Univ Med & Sci, Clin Ctr Res Excellence, Los Angeles, CA 90095 USA
来源：
DIABETES CARE | 2006年 / 29卷 / 06期
关键词：
D O I：
10.2337/dc06-0494
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1395 / 1396
页数：2
相关论文
共 50 条
  • [1] A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia
    Goldberg, RB
    Kendall, DM
    Deeg, MA
    Buse, JB
    Zagar, AJ
    Pinaire, JA
    Tan, MH
    Khan, MA
    Perez, AT
    Jacober, SJ
    [J]. DIABETES CARE, 2005, 28 (07) : 1547 - 1554
  • [2] A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia
    Goldberg, RB
    Kendall, DM
    Deeg, MA
    Buse, JB
    Zagar, AJ
    Pinaire, JA
    Tan, MH
    Khan, MA
    Perez, AT
    Jacober, SJ
    [J]. CIRCULATION, 2005, 111 (13) : 1727 - 1728
  • [3] A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia - Response to Bell and Brunzell
    Goldberg, RB
    Kendall, DM
    Deeg, MA
    Buse, JB
    Zagar, AJ
    Pinaire, JA
    Tan, MH
    Khan, MA
    Perez, AT
    Jacober, SJ
    [J]. DIABETES CARE, 2005, 28 (12) : 2985 - 2986
  • [4] Glycaemic and nonglycaemic effects of pioglitazone in triple oral therapy of patients with type 2 diabetes
    Dorkhan, M.
    Magnusson, M.
    Frid, A.
    Grubb, A.
    Groop, L.
    Jovinge, S.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2006, 260 (02) : 125 - 133
  • [5] Rosiglitazone or pioglitazone in type 2 diabetes?
    de Vries, Corinne S.
    Russell-Jones, David L.
    [J]. BRITISH MEDICAL JOURNAL, 2009, 339
  • [6] A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia - Response to Goldberg et al.
    Brunzell, JD
    [J]. DIABETES CARE, 2005, 28 (12) : 2984 - 2985
  • [7] Dyslipidaemia in Type 2 diabetes: effects of the thiazolidinediones pioglitazone and rosiglitazone
    Mukhtar, R
    Reckless, JPD
    [J]. DIABETIC MEDICINE, 2005, 22 : 6 - 10
  • [8] Triple combination therapy with sitagliptin, metformin, and rosiglitazone improves glycemic control in patients with type 2 diabetes
    Dobs, Adrian
    Goldstein, Barry J.
    Wieczorek, Leon
    Golm, Gregory
    Davies, Michael J.
    Williams-Herman, Debora
    Kaufman, Keith D.
    Amatruda, John M.
    Camilo, Juan
    Ferriera, Arjona
    [J]. DIABETES, 2008, 57 : A595 - A596
  • [9] A comparison of effects of pioglitazone and rosiglitazone on serum lipoproteins and their subfractions in patients with type 2 diabetes and dyslipidemia
    Tan, MH
    Kendall, DM
    Deeg, MA
    Buse, JB
    Goldberg, R
    Zagar, AJ
    Khan, MA
    Perez, AT
    Jacober, SJ
    [J]. DIABETOLOGIA, 2005, 48 : A393 - A394
  • [10] Earlier triple therapy with pioglitazone in patients with type 2 diabetes
    Charpentier, G.
    Halimi, S.
    [J]. DIABETES OBESITY & METABOLISM, 2009, 11 (09): : 844 - 854
12345